2024/03/28 09:08:03 15 minutes delayed | |
---|---|
Price | |
14.30 HKD | |
Difference | 3.92% (0.54) |
ISIN | KYG970081173 |
Symbol | 2269 |
Exchange | Hong Kong Stock Exchange |
Currency | HKD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 7,198 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 13.80 HKD |
High | 15.00 HKD |
Low | 13.80 HKD |
Close (prev. day) | 13.76 HKD |
VWAP | 14.471849 HKD |
Volume (pcs) | - |
Trading volume | - |
Number of trades | - |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 09:08:03 15 minutes delayed | |
---|---|
Price | |
14.30 HKD | |
Difference | 3.92% (0.54) |
ISIN | KYG970081173 |
Symbol | 2269 |
Exchange | Hong Kong Stock Exchange |
Currency | HKD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 7,198 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 13.80 HKD |
High | 15.00 HKD |
Low | 13.80 HKD |
Close (prev. day) | 13.76 HKD |
VWAP | 14.471849 HKD |
Volume (pcs) | - |
Trading volume | - |
Number of trades | - |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -67.57% | -70.39% | -85.41% |
Perf (abs.) | -29.80 | -34.00 | -83.70 |
Beta | 0.69 | 1.02 | 0.63 |
Volatility | 95.99 | 77.16 | 73.34 |
Ø price 5 days | Ø volume 5 days (pcs.) | 13.74 HKD (-) |
Ø price 30 days | Ø volume 30 days (pcs.) | 16.93 HKD (-) |
Ø price 100 days | Ø volume 100 days (pcs.) | 27.97 HKD (-) |
Ø price 250 days | Ø volume 250 days (pcs.) | 37.70 HKD (-) |
YTD High | date | 33.40 HKD (2024/01/11) |
YTD Low | date | 12.94 HKD (2024/03/22) |
52 Weeks High | date | 56.70 HKD (2023/04/14) |
52 Weeks Low | date | 12.94 HKD (2024/03/22) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/03/28 | 10:09 | 1.665 EUR | 0.00 | 5 |
Stuttgart | 2024/03/28 | 10:34 | 1.666 EUR | 0.00 | 2 |
Munich | 2024/03/28 | 08:16 | 1.669 EUR | 0.00 | 1 |
Hong Kong Stock Exchange | 2024/03/28 | 09:08 | 14.30 HKD | - | - |
Frankfurt | 2024/03/28 | 08:09 | 1.667 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/03/26 | 14:41 | 1.735 USD | 0.00 | 2 |
Duesseldorf | 2024/03/28 | 09:30 | 1.658 EUR | 0.00 | 2 |
Berlin | 2024/03/28 | 10:05 | 1.696 EUR | 0.00 | 3 |
WUXI BIOLOGICS (CAYMAN) INC. |
- - |
108, Meiliang Road, Mashan - 214092 Wuxi |
Telefon: + |
Fax: + |
E-mail: - |
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China. |
Zhisheng (Chris) Chen, Ph.D. | Chairman of Managing Board |
Christine Lu-Wong | Member of Executive Committee |
Jijie Gu, Ph.D. | Member of Executive Committee |
Weichang Zhou, Ph.D. | Member of Executive Committee |
Ge Li | Chairman of Supervisory Board |
Jue Chen | Member of Supervisory Board |
Weichang Zhou | Member of Supervisory Board |
Yi Bing Wu | Member of Supervisory Board |
Jackson Tai | Member of Supervisory Board |
Kenneth Hitchner | Member of Supervisory Board |
William Keller | Member of Supervisory Board |
Yan Ling Cao | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer